Honoring Our Fallen Heroes Act of 2025
SB 237, the Honoring Our Fallen Heroes Act of 2025, would expand federal public safety officer death and disability benefits to cover certain cancers linked to occupational exposure. It amends the Omnibus Crime Control and Safe Streets Act of 1968 to create a presumption that exposure to a qualifying carcinogen in the line of duty is a personal injury sustained in the line of duty when specified conditions are met, including service length, timing of diagnosis, and a direct causal connection to death or permanent and total disability. The bill defines a list of covered “exposure-related cancers,” including several common cancers, WTC-related cancers, and any additional cancers later added through an administrative update process.
The bill also establishes a mechanism for updating the cancer list every three years, based on competent medical evidence, and allows any person to petition the Bureau to add a cancer type. It requires the Director to refer qualifying petitions to medical experts within 180 days, consider their recommendations, and notify Congress of substantive actions. In addition, the bill makes related confidentiality and technical amendments to the underlying statute and to the Safeguarding America’s First Responders Act of 2020, including clarifying the meaning of “line of duty action.”
Its practical impact would be to broaden eligibility for federal public safety officer benefits for deaths and disabilities caused by exposure-related cancers, and to apply those changes retroactively to qualifying claims tied to deaths or disabilities on or after January 1, 2020. It also creates a three-year window after enactment for filing claims based on the new cancer presumption, which could affect pending and future claims before the Department of Justice and the Bureau administering the benefit program.
The available legislative context suggests broad bipartisan support and little visible controversy. The bill was introduced by a large bipartisan group of senators and was reported by the Judiciary Committee without amendment, indicating committee-level agreement on the measure’s core purpose. No votes or committee transcripts are provided, so there is no recorded floor debate or formal opposition in the supplied materials.
Any potential contention would likely center on the scope of the cancer presumption, the evidentiary standard for rebutting claims, and the administrative authority to expand the list of covered cancers over time. The bill’s retroactive application and its effect on federal benefit liabilities could also be points of concern, but no specific objections appear in the provided record.
SB 237 would amend 34 U.S.C. 10281 and related provisions to create a federal presumption that certain cancers contracted by public safety officers are line-of-duty injuries when linked to qualifying carcinogen exposure. It would expand eligibility for death and disability benefits, apply to certain claims dating back to January 1, 2020, and require DOJ/Bureau procedures for updating the covered cancer list and handling petitions. The bill also makes conforming confidentiality and technical changes affecting information handling and claim processing under the public safety officer benefits framework.
The bill appears to have strong bipartisan and institutional support. It was introduced by senators from both parties and reported out of committee without amendment, which generally signals consensus on the need to extend benefits to public safety officers with exposure-related cancers. No vote totals, recorded opposition, or hearing transcripts are provided, so the available record reflects support rather than controversy.
No explicit points of contention are documented in the provided materials. Based on the bill text, the most likely areas of debate would be whether the presumption is too broad, whether the 15-year post-service diagnosis window is appropriate, how easily cancers can be added to the list, and whether the government should bear retroactive benefit costs. The rebuttal standard allowing competent medical evidence to defeat the presumption may also be scrutinized by supporters and opponents of broader coverage.